Summary: Maya Singer of Vogue interweaves an explanation of the groundbreaking progress in the expanding psychedelic field and her personal experience with ketamine therapy via telemedicine. Singer interviews psychedelic experts and practitioners to convey the wealth of nuances associated with psychedelic use and brings attention to MAPS-sponsored clinical trials of MDMA-assisted therapy for posttraumatic stress disorder (PTSD).
Originally appearing here.
